M&A Deal Summary

Red Nucleus Acquires Life Science Training Institute

On September 11, 2020, Red Nucleus acquired education company Life Science Training Institute

Acquisition Highlights
  • This is Red Nucleus’ 1st transaction in the Education sector.
  • This is Red Nucleus’ 2nd transaction in the United States.
  • This is Red Nucleus’ 2nd transaction in Pennsylvania.

M&A Deal Summary
Date 2020-09-11
Target Life Science Training Institute
Sector Education
Buyer(s) Red Nucleus
Deal Type Add-on Acquisition

Target

Life Science Training Institute

Horsham, Pennsylvania, United States
Life Science Training Institute (LSTI) is a provider of on-demand and customized compliance training courses for the pharmaceutical, biotech, and medical device industries. LSTI courses offer a wide range of compliance topics covering the entire drug development lifecycle. Life Science Training Institute was formed in 2013 and is based in Horsham, Pennsylvania.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Red Nucleus

Yardley, Pennsylvania, United States
Category Company
Founded 1991
Sector Education
DESCRIPTION

Red Nucleus provides strategic learning and performance solutions exclusively for the life sciences industry. Red Nucleus Enterprises was founded in 1991 and is based in Yardley, Pennsylvania.

DEAL STATS #
Overall 2 of 9
Sector (Education) 1 of 2
Type (Add-on Acquisition) 1 of 7
State (Pennsylvania) 2 of 3
Country (United States) 2 of 8
Year (2020) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-04-02 Pyxa Solutions

Malvern, Pennsylvania, United States

Pyxa Solutions is a provider of consulting, operational, and strategic services supporting life sciences teams. Pyxa Solutions was founded in 2012 and is based in Malvern, Pennsylvania.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-03-04 iTakeControl

Malvern, Pennsylvania, United States

iTakeControl is a provider of clinical operations and medical affairs technology and services focused on rare disease and specialty pharma. ITC’s mobile platform collects patient-reported outcomes and real-world evidence in virtual- and home-based clinical trials and enhances data science in drug development. iTakeControl was founded in 2015 and is based in Malvern, Pennsylvania.

Buy -
Mergr

Product

Company

Legal